Excessive intake of iron and mercury in cardiovascular disease

Forum of Nutrition

Volumn 54, Issue , 1998, Pages 112-126

  Salonen, Jukka T ^a  

^a UNIVERSITY OF EASTERN FINLAND   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

IRON; MERCURY;

ANIMAL; ARTERIOSCLEROSIS; CARDIOVASCULAR DISEASE; HUMAN; LIPID PEROXIDATION; OXIDATIVE STRESS; REVIEW;

ANIMALS; ARTERIOSCLEROSIS; CARDIOVASCULAR DISEASES; HUMANS; IRON; LIPID PEROXIDATION; MERCURY; OXIDATIVE STRESS;

EID: 54249123761     PISSN: 16600347     EISSN: None     Source Type: Book Series    
DOI: 10.1159/000059452     Document Type: Article

References (44)

1. Salonen JT, Ylä-Herttuala S, Yamamoto R, Butler S, Korpela H, Salonen R, Nyyssönen K, Palinski W, Witztum JL: Autoantibody against oxidised LDL and progression of carotid atherosclerosis. Lancet 1992;339:883-887.
2. Salonen JT: Epidemiological studies on LDL oxidation, pro- and antioxidants and atherosclerosis; in Bellomo G, Finardi G, Maggi E, Rice-Evans C (eds): Free Radicals, Lipoprotein Oxidation and Atherosclerosis. London, Richelieu Press, 1995.
3. Salonen JT: The role of lipid peroxidation and natural antioxidants in cardiovascular diseases; in Kumpulainen JT, Salonen JT (eds): Natural Antoxidants and Food Quality in Atherosclerosis and Cancer Prevention. Cambridge, The Royal Society of Chemistry, 1996, pp 3-6.
4. Truswell AS: ABC of nutrition. Some principles. Br Med J 1985;291:1486-1490.
5. Salonen JT: The role of iron as a cardiovascular risk factor. Curr Opin Lipidol 1993;4:277-282.
6. Gutteridge JMC, Halliwell B: Iron toxicity and oxygen radicals. Baillière's Clinical Haematology 1989;2:195-256.
7. Halliwell B, Gutteridge JMC: Role of free radicals and catalytic metal ions in human disease: An overview. Methods Enzymol 1990;186:1-85.
8. Ryan TP, Aust SD: The role of iron in oxygen-mediated toxicities. Crit Rev Toxicol 1992;22:119-141.
9. Van Dyke BP, Saltman P: Hemoglobin: A mechanism for the generation of hydroxyl radicals. Free Radic Biol Med 1996;20:985-989.
10. Stohs SJ, Bagghi D: Oxidative mechanisms in the toxicity of metal ions. Free Radic Biol Med 1995; 18:321-336.
11. Rice-Evans CA, Baysal E: Iron-mediated oxidative stress in erythrocytes. Biochem J 1987;244: 191-196.
12. Salonen JT: Body iron stores, lipid peroxidation and coronary heart disease; in Hallberg L, Asp N-G (eds): Iron Nutrition in Health and Disease. London, Libbey, 1996, pp 293-301.
13. Salonen JT, Korpela H, Nyyssönen K, Porkkala E, Tuomainen T-P, Belcher JD, Jacobs DR Jr, Salonen R: Lowering of body iron stores by blood letting and oxidation resistance of serum lipoproteins: A randomized cross-over trial in smoking men. J Intern Med 1995;237:161-168.
14. Araujo JA, Romano EL, Brito BE, Parthe V, Romano M, Bracho M, Montano RF, Cardier J: Iron overload augments the development of atherosclerotic lesions in rabbits. Arterioscler Thromb Vase Biol 1995;15:1172-1180.
15. Weiner MA, Paige SB, Bailey SR: Antioxidant therapy decreases atherosclerotic plaque burden in an iron loaded animal model (abstract 2241). Eur Heart J 1994;15(suppl):425.
16. Kiechl S, Aichner F, Gerstenbrand F, Egger G, Mair A, Rungger G, Spögler F, Jarosch E, Oberhollenzer F, Willeit J: Body iron stores and presence of carotid atherosclerosis. Results from the Bruneck Study. Arterioscler Thromb 1994;14:1625-1630.
17. Moore M, Folsom AR, Barnes RW, Eckfeldt JH: No association between serum ferritin and asymptomatic carotid atherosclerosis. The Atherosclerosis Risk in Communities (ARIC) Study. Am J Epidemiol 1995;141:719-723.
18. Salonen JT, Nyyssönen K, Korpela H, Tuomilehto J, Seppänen R, Salonen R: High stored iron levels are associated with excess risk of myocardial infarction in eastern Finnish men. Circulation 1992;86:803-811.
19. Salonen JT, Nyyssönen K, Salonen R: Body iron stores and the risk of coronary heart disease. N Engl J Med 1994;331:1159.
20. Morrison HI, Semenciw RM, Mao Y, Wigle DT: Serum iron and risk of fatal acute myocardial infarction. Epidemiology 1994;5:243-246.
21. Magnusson MK, Sigfusson N, Sigvaldason H, Johannesson GM, Magnusson S, Thorgeirsson G: Low iron-binding capacity as a risk factor for myocardial infarction. Circulation 1994;89:102-108.
22. Sempos CT, Looker AC, Gillum RF, Makuc DM: Body iron stores and the risk of coronary heart disease. N Engl J Med 1994;330:1119-1124.
23. Reunanen A, Takkunen H, Knekt P, Seppanen R, Aromaa A: Body iron stores, dietary iron intake and coronary heart disease mortality. J Intern Med 1995;238:223-230.
24. Ascherio A, Willet WC, Rimm EB, Giovannucci E, Stampfer MJ: Dietary iron intake and risk of coronary heart disease. Circulation 1994;89:969-974.
25. Baer DM, Tekawa IS, Hurley LB: Iron stores are not associated with acute myocardial infarction. Circulation 1994;89:2915-2918.
26. Van Asperen IA, Feskens EJ, Bowles CH, Kromhout D: Body iron stores and mortality due to cancer and ischaemic heart disease: A 17-year follow-up. Inter J Epidemiol 1995;24:665-670.
27. Hallberg L: Poster. 'The Role of Trace Elements for Health Promotion and Disease Prevention', Copenhagen, August 1996.
28. Feder JN, Gnirke A, Thomas W, Tsuchihashi Z, Ruddy DA, Basava A, Dormishian F, Domingo R Jr, Ellis MC, Fullan A, Hinton LM, et al: A novel MHC class I-like gene is mutated in patients with hereditary haemochromatosis. Nat Genet 1996;13:375-376.
29. Halliwel B, Gutteridge JMC: Free Radicals in Biology and Medicine, ed 2. Oxford, Clarendon Press, 1989.
30. International Programme on Chemical Safety (IPCS): Environmental health criteria 101. Methylmercury. Geneva, World Health Organization, 1990.
31. Salonen R, Nyyssönen K, Porkkala E, Rummukainen J, Beider R, Park J-S, Salonen JT: Kuopio Atherosclerosis Prevention Study (KAPS): A population-based primary preventive trial of the effect of LDL lowering on atherosclerotic progression in carotid and femoral arteries. Circulation 1995; 92:1758-1764.
32. Salonen JT, Seppänen K, Nyyssönen K, Korpela H, Kauhanen J, Kantola M, Tuomilehto J, Esterbauer H, Tatzber F, Salonen R: Intake of mercury from fish, lipid peroxidation and the risk of myocardial infarction and coronary, cardiovascular and any death in Eastern Finnish men. Circulation 1995;91:645-655.
33. Jansson G, Harms-Ringdahl M: Stimulating effects of mercuric- and silver ions on the superoxide anion production in human polymorphonuclear leucocytes. Free Radic Res Comms 1993;18:87-98.
34. Miller OM, Lund BO, Woods JS: Reactivity of Hg(II) with superoxide: Evidence for the catalytic dismutation of superoxide by Hg(II). J Biochem Toxicol 1991;6:293-298.
35. 2 formation and oxidative stress in vivo and in vitro in rat kidney mitochondria. Biochem Pharmacol 1993;45:2017-2024.
36. Rungby J, Ernst E: Experimentally induced lipid peroxidation after exposure to chromium, mercury or silver: Interactions with carbon tetrachloride. Pharmacol Toxicol 1992;70:205-207.
37. Naganuma A, Koyama Y, Imura N: Behavior of methylmercury in mammalian erythrocytes. Toxicol Appl Pharmacol 1980;54:405-410.
38. Benov LC, Benchev IC, Monovich OH: Thiol antidotes effect on lipid peroxidation in mercury-poisoned rats. Chem Biol Interact 1990;76:321-332.
39. Cuvin-Aralar ML, Furness RW: Mercury and selenium interaction: A review. Ecotoxicol Environ Safety 1991;21:348-364.
40. Gonzalvo MC, Gil F, Hernandez AF, Villan E, Pla A: Inhibition of paraoxonase activity in human liver microsomes by exposure to EDTA, metals and mercurials. Chem Biol Interact 1997;105:169-179.
41. Salonen JT, Alfthan G, Huttunen JK, Pikkarainen J, Puska P: Association between cardiovascular death and myocardial infarction and serum selenium in a matched-pair longitudinal study. Lancet 1982;2:175-179.
42. Salonen JT, Salonen R, Seppänen K, Kantola M, Suntioinen S, Korpela H: Interactions of serum copper, selenium, and low density lipoprotein cholesterol in atherogenesis. Br Med J 1991;302: 756-760.
43. Lu KP, Zhao SH, Wang DS: The stimulatory effect of heavy metal cations on proliferation of aortic smooth muscle cells. Schi China B 1990;33:303-310.
44. Kostka B: Potentiation of ADP-induced platelet aggregation by mercury compounds. Thromb Res 1990;57:795-801.